MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • MDS Virtual Congress 2020

    Prevalence and Characteristics of Postural Deformities in Thai Patients with Parkinson’s Disease

    T. Wangthumrong, C. Pongmala, Y. Pitakpatapee, J. Srikajon, M. Vichutavate, P. Srivanitchpoom (Bangkok, Thailand)

    Objective: We aimed to investigate the prevalence, clinical characteristics and quality of life (QoL) in Thai Parkinson's disease (PD) patients with postural deformities (PostD) and…
  • MDS Virtual Congress 2020

    Motor subtype change between OFF and ON periods in patients with Parkinson’s disease

    O. Esquivel-Zapata, A. Abundes-Corona, F. Herrera-Rodriguez, O. Cardenas-Saenz, E. Escobar-Valdivia, Y. Ríos-Solís, H. Tellez-Lucero, A. Cervantes-Arriaga, M. Rodriguez-Violante (Mexico, Mexico)

    Objective: To identify if there is any difference in the motor subtype of PwPD between "off" stage and "on" stage. Background: Patients with Parkinson’s disease…
  • MDS Virtual Congress 2020

    New compound increasing glucocerebrosidase activity on primary cell cultures obtained from patients with GBA-associated Parkinson’s disease

    M. Nikolaev, A. Kopytova, K. Senkevich, G. Baydakova, I. Miliukhina, E. Zakharova, G. Rychkov, A. Cheblokov, F. Ibatullin, S. Pchelina, A. Emelyanov (Gatchina, Russian Federation)

    Objective: To determine whether new chemical modifications of the previously described allosteric GCase chaperone N607 (Aflaki E et.al Neurosc. 2016) increase GCase activity in monocyte-derived…
  • MDS Virtual Congress 2020

    Disease stage and UMSARS progression: Implications for clinical trials

    M. Pérez, J.A Palma, L. Norcliffe-Kaufmann, P. Millar Vernetti, W. Singer, P. Low, M.T Pellecchia, H.J Kim, C. Shibao, A. Peltier, I. Biaggioni, D. Giraldo, M.J Martí, A. Fanciulli, C. Terroba-Chambi, M. Merello, D. Goldstein, R. Freeman, C. Gibbons, S. Vernino, F. Krismer, G. Wenning, H. Kaufmann (New York, NY, USA)

    Objective: To study the rate of progression of multiple system atrophy (MSA) and assess for a potential ceiling effect of the Unified Multiple System Atrophy…
  • MDS Virtual Congress 2020

    Development and validation of a profile of peripheral immune biomarkers for Parkinson’s disease: A multicenter, retrospective study

    Y. Li, J. Liu (Shanghai, China)

    Objective: This multicenter study was designed to investigate the association between multiple peripheral immune biomarkers and the risk of Parkinson’s disease (PD). Background: Several studies…
  • MDS Virtual Congress 2020

    Does “5-2-1” identify patients with suspected Advanced Parkinson’s Disease? Evidence of clinical accuracy from G7 countries

    A. Antonini, P. Odin, T. Henriksen, M. Soileau, R. Rodriguez-Cruz, A. Alobaidi, Y. Jalundhwala, P. Kandukuri, J.C Parra, K. Onuk, P. Kukreja, A. Gillespie, J. Pike, K.R Chaudhuri (North Chicago, IL, USA)

    Objective: Evaluate the psychometric properties of (i) the “5-2-1” criteria and (ii) consensus-driven clinical indicators of suspected advanced Parkinson’s disease (APD). Background: Recent consensus panel…
  • MDS Virtual Congress 2020

    The efficacy of traditional Mikkyo Buddhism meditation in stress management of Parkinson’s syndrome patients

    S. Murahashi, Y. Takeuchi, Y. Hara (Yatsushiro, Japan)

    Objective: To investigate the efficacy of Asokukan in stress management of Parkinson’s syndrome patients. Background: Stress management is very important in intractable neurological diseases. Currently,…
  • MDS Virtual Congress 2020

    Improvement in the handicap is maintained after 5 years of deep brain stimulation in Parkinson’s disease

    D. Silva, M. Fabbri, L. Guedes, A. Caldas, P. Lobo, B. Cattoni, H. Carvalho, A. Ferreira, M. Rosa, J. Ferreira, M. Coelho (Lisbon, Portugal)

    Objective: To characterize the handicap after 4.8 years of DBS-STN and to compare with pre-surgery data. Background: The London Handicap Scale (LHS) provide an overall…
  • MDS Virtual Congress 2020

    Spinal Cord Stimulation on Parkinson’s disease: Continuous or intermittent stimulation?

    R. Carra, J. Menezes, R. Magalhaes, I. Kayo, M. Teixeira, K. Duarte, D. Andrade, E. Barbosa, T. Capato, R. Cury (Sao Paulo, Brazil)

    Objective: To report the effects of continuous and intermittent spinal cord stimulation (SCS) on gait in two patients with Parkinson’s disease (PD) with refractory gait…
  • MDS Virtual Congress 2020

    Overcoming Stimulation-Related Side Effects And Improving Outcome By Proper Programing Of Subthalamic Stimulation Of Parkinson’s Disease: Cases Report

    A. Shalash, E. Hamid, Z. Fayed (Cairo, Egypt)

    Objective: We reported three cases of subthalamic deep brain stimulation (STN-DBS) of Parkinson’s disease (PD), with successful management of challenging issues during programing. Background: Proper…
  • « Previous Page
  • 1
  • …
  • 67
  • 68
  • 69
  • 70
  • 71
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley